Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on North America OTC Health Products Market
5.1. COVID-19 Landscape: North America OTC Health Products Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global North America OTC Health Products Market, By Product
8.1. North America OTC Health Products Market, by Product, 2022-2030
8.1.1. Cough, Cold, and Flu Products
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Dietary Supplements and Weight Loss Products
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Sports Nutrition Products
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Probiotics
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. CBD Nutraceutical Products
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global North America OTC Health Products Market, By Form
9.1. North America OTC Health Products Market, by Form, 2022-2030
9.1.1. Liquid
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Capsules/Tablets
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Gummies
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global North America OTC Health Products Market, By Demography
10.1. North America OTC Health Products Market, by Demography, 2022-2030
10.1.1. Children
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Adults
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global North America OTC Health Products Market, By Application
11.1. North America OTC Health Products Market, by Application, 2022-2030
11.1.1. Digestive health
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Women’s & Men’s Health
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Weight Control
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Joint health
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Immune Defense
11.1.5.1. Market Revenue and Forecast (2017-2030)
11.1.6. Sports Formulation
11.1.6.1. Market Revenue and Forecast (2017-2030)
11.1.7. Others
11.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global North America OTC Health Products Market, By May
12.1. North America OTC Health Products Market, by May, 2022-2030
12.1.1. Introduction
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. IDM
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Foundries
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. OSAT
12.1.4.1. Market Revenue and Forecast (2017-2030)
12.1.5. Others
12.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global North America OTC Health Products Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.2. Market Revenue and Forecast, by Form (2017-2030)
13.1.3. Market Revenue and Forecast, by Demography (2017-2030)
13.1.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.5. Market Revenue and Forecast, by May (2017-2030)
Chapter 14. Company Profiles
14.1. Herbalife Nutrition
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. CV Sciences, Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Medical Marijuana Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Nature's Sunshine Products Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Johnson and Johnson Services, LLC
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. GlaxoSmithKline Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Bayer AG
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. American Health
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. THE BOUNTIFUL COMPANY (Nestlé Health Science S.A.)
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Abbott
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms